Our search strategy employed key terms such as “Type 2 Diabetes”, “SGLT2 inhibitors”, “GLP-1 receptor agonists”, “tirzepatide”, “Glimins”, “Glucokinase activators”, and “multifactorial care”. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.